Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
Six months after the publication of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sequence, a record number of vaccine candidates were listed, and quite a number of them have since been approved for emergency use against the novel coronavirus disease 2019 (COVID-19). This unpreced...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/bf7b697a21b34619b8042c67ff89a092 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|